Wedbush upgraded Healthpeak Properties from Neutral to Outperform
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/15/2025 | $25.00 | Equal-Weight → Overweight | Morgan Stanley |
| 10/21/2024 | $20.00 → $28.00 | Hold → Buy | Deutsche Bank |
| 5/3/2024 | Neutral → Outperform | Wedbush | |
| 4/26/2024 | $19.00 → $21.00 | Neutral → Outperform | Exane BNP Paribas |
| 4/22/2024 | $22.00 | Buy | Mizuho |
| 4/1/2024 | $18.00 → $25.00 | Underperform → Buy | BofA Securities |
| 3/25/2024 | $19.00 | Equal Weight | Wells Fargo |
| 3/8/2024 | $21.00 | Outperform | RBC Capital Mkts |
4 - HEALTHPEAK PROPERTIES, INC. (0000765880) (Issuer)
4 - HEALTHPEAK PROPERTIES, INC. (0000765880) (Issuer)
4 - HEALTHPEAK PROPERTIES, INC. (0000765880) (Issuer)
8-K - HEALTHPEAK PROPERTIES, INC. (0000765880) (Filer)
S-8 - HEALTHPEAK PROPERTIES, INC. (0000765880) (Filer)
8-K - HEALTHPEAK PROPERTIES, INC. (0000765880) (Filer)